Transcriptional suppression of in vitro-integrated human immunodeficiency virus type 1 does not correlate with proviral DNA methylation.
about
Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissueSilencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanismsLatency: the hidden HIV-1 challenge.Epigenetic regulation of HIV-1 latency by cytosine methylationCpG methylation controls reactivation of HIV from latency.Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.Epigenetic analysis of HIV-1 proviral genomes from infected individuals: predominance of unmethylated CpG's.Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.Designed transcription activator-like effector proteins efficiently induced the expression of latent HIV-1 in latently infected cells.High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms.Dual-reporter phenotypic assay for human immunodeficiency virusesDevelopment of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individualsTargeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins.Regulation of HIV-1 latency by T-cell activation.HIV-1 transcription and latency: an update.Chromatin, gene silencing and HIV latencyHIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.Specific and Stable Suppression of HIV Provirus Expression In Vitro by Chimeric Zinc Finger DNA Methyltransferase 1.Achieving a cure for HIV infection: do we have reasons to be optimistic?5' long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals.LGIT In Vitro Latency Model in Primary and T Cell Lines to Test HIV-1 Reactivation Compounds.Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.Source of CpG Depletion in the HIV-1 Genome.Mobilization-competent Lentiviral Vector-mediated Sustained Transcriptional Modulation of HIV-1 Expression.Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction.Determinants of the establishment of human immunodeficiency virus type 1 latency.Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation.An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infectionHIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing.
P2860
Q24562082-A64DEE9D-43DA-40A1-B06C-2E5BD1DACD63Q24811510-0A176DDF-BEA3-4ACC-A36B-4C87A55772DBQ25255905-50BC7A56-F055-4852-9B75-088956DE3EBAQ28475636-1BC831BD-46E1-462F-92D0-017D077679D8Q33495565-16A98865-2D7E-4B29-A2D8-4E11B3DC8CA4Q33587139-99C3F83D-B2D3-410D-A90A-70A719B880C7Q33768729-5AA6F71B-C744-4114-8F87-FA88F4349083Q34132738-3CA6FD00-E052-4BB9-95D9-D576093ED1A4Q34671609-75CD4415-9218-4887-82B8-B832268EE4C1Q34870253-5D1F80FD-26A6-4DAE-A9E5-0C94F77782CDQ35784937-860E4A5D-79D3-4E81-AF00-ADED93C170FCQ36452419-621E973A-DB21-4A80-BA0C-2E794299F383Q36596027-04BC9C97-38AB-4DAC-B8A7-E2E85B868C6DQ36759698-B2B18AF4-0BD4-46F8-99A9-319E4EF637B4Q36887625-67E5AAA5-E9DA-43AA-9868-01DDED59CD95Q36976156-FF98F2F5-65B1-48AF-98F8-E52B505B5FDBQ37013167-E78C620A-457A-4738-A1C8-3B8623FFB773Q37607912-D90A05CD-FD51-49F4-895A-75EA0CFC2FB2Q37644561-5265B573-AB72-4992-BDEC-ACFDE67DBBE2Q37718212-C03DDB18-2D31-41DF-A717-2BA345AF64E9Q37980423-E8147436-F8D1-4835-BF56-1797634BD65EQ38758956-BAD842BF-A50E-497F-AA12-E5FFFE861D4DQ38808202-5ED1F4A1-61AF-4ACE-A044-0ECFB0E281DBQ39331564-F03C715B-5345-4A96-ACAA-93B5CFACC753Q39341707-BD36E9FA-C9FC-4CDB-8A13-108D033D6940Q39503586-A0F2EA71-4329-4B72-9845-C0607F3B80C5Q39712159-919F59E7-AE9F-4450-AFAE-03F8DDB8DF76Q39895237-FA9674F0-52F8-4066-9BFB-E6FB574F4826Q40091545-6DA421E2-E513-4233-88B2-082AFC38357BQ41961224-2934B003-59B4-4926-B301-90047F24679CQ52680785-A66978C8-B65C-486B-983A-7280E06F1025
P2860
Transcriptional suppression of in vitro-integrated human immunodeficiency virus type 1 does not correlate with proviral DNA methylation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Transcriptional suppression of ...... with proviral DNA methylation.
@ast
Transcriptional suppression of ...... with proviral DNA methylation.
@en
Transcriptional suppression of ...... with proviral DNA methylation.
@nl
type
label
Transcriptional suppression of ...... with proviral DNA methylation.
@ast
Transcriptional suppression of ...... with proviral DNA methylation.
@en
Transcriptional suppression of ...... with proviral DNA methylation.
@nl
prefLabel
Transcriptional suppression of ...... with proviral DNA methylation.
@ast
Transcriptional suppression of ...... with proviral DNA methylation.
@en
Transcriptional suppression of ...... with proviral DNA methylation.
@nl
P2093
P2860
P1433
P1476
Transcriptional suppression of ...... with proviral DNA methylation.
@en
P2093
Albert Jordan
Angelique Biancotto
Eric Verdin
Françoise Gondois-Rey
Jiri Hejnar
Marjorie Pion
Robert Vigne
Sophie Rondeau
P2860
P304
P356
10.1128/JVI.77.7.4025-4032.2003
P407
P577
2003-04-01T00:00:00Z